Insomnie bei postmenopausalem Syndrom

Epidemiologische Studien, wie die US-amerikanische Women’s Health Initiative (WHI) Study (1) oder die australische Healthy Aging of Women (HOW) Study (2), zeigten, dass 24,5 bzw. 23 % der postmenopausalen Frauen an Insomnie leiden, die wiederum mit physischen, emotionalen und gemischten Störungen assoziiert ist.

• Literatur

• 1 Zaslavsky O, LaCroix AZ, Hale L, Tindle H, Shochat T. Longitudinal changes in insomnia status and incidence of physical, emotional, or mixed impairment in postmenopausal women participating in the Women’s Health Initiative (WHI) study. Sleep Med 2015; 16 (03) 364-371.
• 2 Seib C, Anderson K, Lee K. Prevalence and correlates of sleep disturbance in postmenopausal women: the Australian Healthy Aging of Women (HOW) Study. J Women’s Health 2014; 23 (02) 151-158.
• 3 Shaver JLF, Giblin E, Paulsen V. Sleep quality subtypes in midlife women. Sleep 1991; 14 (01) 18-23.
• 4 Saletu-Zyhlarz G, Anderer P, Gruber G. et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien^®, Lafamme^®) versus estrogen alone. J Sleep Res 2003; 12: 239-254.
• 5 Hunter MS. Psychological and somatic experience of the menopause: A prospective study. Psychosom Med 1990; 52: 357-367.
• 6 Hunter M. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 1992; 14: 117-126.
• 7 Hunter M, Battersby R, Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas 1986; 8: 217-228.
• 8 Kujak J, Young T. The average month-to-month effect of menopausal symptoms on sleep complaints. Abstract Book, 11th Annual Meeting – Associated Professional Sleep Studies. San Francisco: 1997: 384.
• 9 Feinberg I. Effects of age on human sleep patterns. In: Kales A. (Ed) Sleep Physiology and Pathology. Lippincott, Philadelphia: 1969: 39-52.
• 10 Strauch I, Dubral I, Struchholz C. Sleep behavior in adolescents in relation to personality variables. In: Jovanovic. (Ed) The Nature of Sleep. Fischer; Stuttgart: 1973: 121-131.
• 11 Tune GA. The influence of age and temperament on the adult human sleep-wakefulness pattern. Br J Psychol 1969; 60: 431-441.
• 12 Webb WB. The different functional relationships of REM and stage 4 sleep. In: Jovanovic. (Ed) The Nature of Sleep. Fischer; Stuttgart: 1973: 256-258.
• 13 Saletu B, Saletu-Zyhlarz GM. Was Sie schon immer über Schlaf wissen wollten. Wien: Ueberreuter; 2001
• 14 Anderer P, Gruber G, Klösch G. et al. Effects of normal aging on subjective and objective measures of sleep. Journal of Sleep Research 2000; 9 (Suppl. 01) 4.
• 15 Saletu B, Anderer P, Frey R. et al. Zur Neurophysiologie des Schlafes/Some remarks about the neurophysiology of sleep. Psychiatria Danubina 1991; 3: 31-58.
• 16 Saletu B, Altmann S. Faszination Schlaf. Schäfchen zählen war gestern. Wien: maudrich Verlag; 2015
• 17 Anderer P, Saletu B, Pascual-Marqui RD, Semlitsch HV. EEG and ERP topography and tomography in normal aging. In: Saletu B, Krijzer F, Ferber G, Anderer P. (Eds). Electrophysiological Brain Research in Preclinical and Clinical Pharmacology and Related Fields – An Update. Wien: Facultas Universitätsverlag; 2000: 122-138.
• 18 Dietzel M, Saletu B, Lesch OM, Sieghart W, Schjerve M. Light treatment in depressive illness. Polysomnographic, psychometric and neuroendocrinological findings. Eur Neurol 1986; 25 (Suppl. 02) 93-103.
• 19 Reynolds CF, Kupfer DJ. Sleep research in affective illness: State of the art. Sleep 1987; 10: 199-215.
• 20 Saletu-Zyhlarz GM, Hassan Abu-Bakr M. et al. Insomnia in depression: Differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Progress in Neuropsychopharmacology & Biological Psychiatry 2002; 26: 249-260.
• 21 Saletu-Zyhlarz G, Hassan Abu-Bakr M. et al. Insomnia related to dysthymia: Polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology 2001; 44 (03) 142-150.
• 22 Saletu B, Anderer P, Brandstätter N. et al. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). Neuropsychobiology 1994; 29: 69-90.
• 23 Saletu-Zyhlarz G, Saletu B, Anderer P. et al. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology 1997; 36: 117-129.
• 24 Saletu-Zyhlarz GM, Anderer P, Berger P. et al. Nonorganic insomnia in panic disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam. Human Psychopharmacology 2000; 15: 241-254.
• 25 Saletu M, Hauer C, Anderer P. et al. Tagesmüdigkeit korreliert mit nächtlichen Atmungs- und Arousal-Variablen bei Schlafapnoepatienten: Polysomnographische und EEG-Mapping-Untersuchungen. Wien Klin Wochenschr 2000; 112 (06) 281-289.
• 26 Saletu B, Gruber G, Saletu M. et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality. Neuropsychobiology 2000; 41: 181-189.
• 27 Saletu M, Anderer P, Saletu B. et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology 2000; 41: 190-199.
• 28 Saletu M, Anderer P, Saletu B. et al. Sleep laboratory studies in periodic limb movement disorder (PLMD) as compared with normals and acute effects of ropinirole. Human Psychopharmacology Clinical and Experimental 2001; 16 (02) 177-187.
• 29 Linzmayer L, Semlitsch HV, Saletu B. et al. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneim Forsch Drug Res 2001; 51 (I) 238-245.
• 30 Saletu B, Anderer P, Gruber D. et al. Hormone replacement therapy and vigilance: Double-blind, placebo-controlled EEG mapping studies with an estrogen-progestogen regimen (Climodien®, Lafamme®) versus estrogen alone in menopausal insomnia patients. Maturitas 2002; 43 (03) 165-181.
• 31 Anderer P, Semlitsch HV, Saletu B. et al. Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia. Psychoneuroendocrinology 2003; 28: 419-445.
• 32 Baumgartner A, Dietzel M, Saletu B. et al. Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone and estradiol in healthy young women. Psychiatry Research 1993; 48: 153-178.